Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Identification of a sporozoite-specific antigen from Toxoplasma gondii.
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.
Clinical update on COVID-19 for the emergency clinician: Airway and resuscitation.
Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Lorcainide therapy for the high-risk patient post myocardial infarction.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lorcainide therapy for the high-risk patient post myocardial infarction.
Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
View in:
PubMed
subject areas
Aged
Anti-Arrhythmia Agents
Benzeneacetamides
Blood Pressure
Death, Sudden
Drug Evaluation
Electrocardiography
Female
Heart Ventricles
Humans
Lidocaine
Male
Middle Aged
Myocardial Infarction
Piperidines
Procainamide
Risk
Tachycardia